Gastrointestinal Cancer Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1063127
  • May 2021
  • Medical Devices
  • 134 Pages
The global Gastrointestinal Cancer Devices market research report provides complete study and detail analysis of the market. This study includes forecast analysis of the market which is based on global and regional level, whereas the research reports the provides forecast data from 2020-2028 and historic of 2018 and 2019. All the values are based on revenue USD Million. Moreover, the market research report describes various segments of the Gastrointestinal Cancer Devices market based on its types, applications and end-use industry. The applications of the market are explained in different industry verticals with reference to major countries across the globe. Along with this, the research report also covers all the major players that are operating in the global Gastrointestinal Cancer Devices market. These major players of the market are further studied and analyzed based on various parameters, such as annual market revenue, annual sales of the company, marketing strategy, historic growth and shipment volumes. Based on all the company’s insights, the market research analyst also suggests business strategy and marketing plans for improving the market position of existing participants of Gastrointestinal Cancer Devices market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Eli Lilly and company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Merck & Co., Inc., Novartis AG, Otsuka Holdings Co., Ltd., Stryker Corporation, Boston Scientific Corporation, Johnson & Johnson, CONMED Corporation
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Apart from this, the market research report also covers drivers and restraints for the global Gastrointestinal Cancer Devices market and their impact on the demand and supply during the forecast period. Along with this, the research report also provides Gastrointestinal Cancer Devices market trends and opportunities that are based on regional and global level. Furthermore, the market research report also provides the major distributors and manufacturers that are operating in all the key region across the world. The researched data provided in the report is widely used by various industry players to strengthen their distribution channel and improve the geographical reach. In addition, the report also covers all the major players of the global Gastrointestinal Cancer Devices market and its key offerings and solutions. The report also provides recent mergers and acquisitions of these key players.

The data which is provided in the market research report is analyzed and evaluated with the help of various marketing tools, such as SWOT analysis, Poster’s Five Force analysis, PESTEL analysis, value chain analysis, player positioning analysis and market share analysis. Therefore, this analysis tools helps the analyst to evaluate the Gastrointestinal Cancer Devices market based on various parameters such as capital investments, impact of consumer’s preferences, economies of scale, manufacturing rights and patents, existing distribution channels, switching costs, government regulations and brand loyalty.

Major Key Players for Global Gastrointestinal Cancer Devices Market:
The Gastrointestinal Cancer Devices market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Eli Lilly and company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Merck & Co., Inc., Novartis AG, Otsuka Holdings Co., Ltd., Stryker Corporation, Boston Scientific Corporation, Johnson & Johnson, CONMED Corporation

Gastrointestinal Cancer Devices Market Segment Analysis:
By Treatment Type
Surgery
Targeted Drugs Therapy
Chemo Therapy
Radiation Therapy
End User
Hospitals
Ambulatory Surgery Centers
Others


Geographic Coverage for Gastrointestinal Cancer Devices Market:
The market research report on global Gastrointestinal Cancer Devices market offers complete analysis across various regions across the world. The Gastrointestinal Cancer Devices market is distributed into various regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The global leading market share as per the region is evaluated after considering Gastrointestinal Cancer Devices market revenue, sales, shares, recent developments, innovations and growth rates. This section of regional analysis provides widespread evaluation of the industry from various countries and regions.

North America Gastrointestinal Cancer Devices Market Value and Forecast
  • US
  • Canada
Europe Gastrointestinal Cancer Devices Market Value and Forecast
  • UK
  • Germany
  • France
  •  Rest of Europe
Asia Pacific Gastrointestinal Cancer Devices Market Value and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Gastrointestinal Cancer Devices Market Value and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Gastrointestinal Cancer Devices Market Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Key highlights of the Gastrointestinal Cancer Devices market report:
  • The report provides key trends of the global Gastrointestinal Cancer Devices market
  • The report also covers consumer preferences and current industry growth
  • Key products or solutions offered by the main players in the Gastrointestinal Cancer Devices industry
  • The report covers all the recent developments of the Gastrointestinal Cancer Devices market and helps to provide current industry updates
  • The report covers a detailed look over the global Gastrointestinal Cancer Devices Industry and provides with significant actionable insights
  • The Gastrointestinal Cancer Devices market estimation from 2020-2028 and historical data for 2018 and 2019
  • The market study also provides data on changing market dynamics, market intelligence, current and future market trends
  • The report also analyses the microeconomic and macroeconomic factors that are affecting the global Gastrointestinal Cancer Devices market
  • In-depth analysis of the market’s competitive landscape and detailed information about the vendors
  • The report also offers key market drivers, restrains, trends and opportunities with present and future impact on the market
  • Detailed information about the major players or manufacturers of the global Gastrointestinal Cancer Devices market
  • Comprehensive analysis of the Gastrointestinal Cancer Devices market segments based on its types, applications and end-use industry
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Gastrointestinal Cancer Devices market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Gastrointestinal Cancer Devices market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

      2.  Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Gastrointestinal Cancer Devices market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Gastrointestinal Cancer Devices market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

      3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Gastrointestinal Cancer Devices market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Eli Lilly and company
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis AG
  • Otsuka Holdings Co., Ltd.
  • Stryker Corporation
  • Boston Scientific Corporation
  • Johnson & Johnson
  • CONMED Corporation
  • Surgery
  • Targeted Drugs Therapy
  • Chemo Therapy
  • Radiation Therapy
  • Hospitals
  • Ambulatory Surgery Centers
  • Others

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Gastrointestinal Cancer Devices Market Snapshot
          2.1.1. Global Gastrointestinal Cancer Devices Market By Treatment Type,2019
               2.1.1.1.Surgery
               2.1.1.2.Targeted Drugs Therapy
               2.1.1.3.Chemo Therapy
               2.1.1.4.Radiation Therapy
          2.1.2. Global Gastrointestinal Cancer Devices Market By End User,2019
               2.1.2.1.Hospitals
               2.1.2.2.Ambulatory Surgery Centers
               2.1.2.3.Others
          2.1.3. Global Gastrointestinal Cancer Devices Market By End-use,2019
          2.1.4. Global Gastrointestinal Cancer Devices Market By Geography,2019

3. Global Gastrointestinal Cancer Devices Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Gastrointestinal Cancer Devices Market Size (US$), By Treatment Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Treatment Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Treatment Type, 2020
     4.2. Global Gastrointestinal Cancer Devices Market Size (US$), By Treatment Type, 2018 – 2028

5. Global Gastrointestinal Cancer Devices Market Size (US$), By End User, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By End User, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By End User, 2020
     5.2. Global Gastrointestinal Cancer Devices Market Size (US$), By End User, 2018 – 2028

6. Global Gastrointestinal Cancer Devices Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Gastrointestinal Cancer Devices Market Size (US$), By End-use, 2018 – 2028

7. Global Gastrointestinal Cancer Devices Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Gastrointestinal Cancer Devices Market Analysis, 2018 – 2028 
          7.2.1. North America Gastrointestinal Cancer Devices Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Gastrointestinal Cancer Devices Market Size (US$), By Treatment Type, 2018 – 2028
          7.2.3. North America Gastrointestinal Cancer Devices Market Size (US$), By End User, 2018 – 2028
          7.2.4. North America Gastrointestinal Cancer Devices Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Gastrointestinal Cancer Devices Market Analysis, 2018 – 2028 
          7.3.1.  Europe Gastrointestinal Cancer Devices Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Gastrointestinal Cancer Devices Market Size (US$), By Treatment Type, 2018 – 2028
          7.3.3. Europe Gastrointestinal Cancer Devices Market Size (US$), By End User, 2018 – 2028
          7.3.4. Europe Gastrointestinal Cancer Devices Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Gastrointestinal Cancer Devices Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Gastrointestinal Cancer Devices Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Gastrointestinal Cancer Devices Market Size (US$), By Treatment Type, 2018 – 2028
          7.4.3. Asia Pacific Gastrointestinal Cancer Devices Market Size (US$), By End User, 2018 – 2028
          7.4.4. Asia Pacific Gastrointestinal Cancer Devices Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Gastrointestinal Cancer Devices Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Gastrointestinal Cancer Devices Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Gastrointestinal Cancer Devices Market Size (US$), By Treatment Type, 2018 – 2028
          7.5.3. Latin America Gastrointestinal Cancer Devices Market Size (US$), By End User, 2018 – 2028
          7.5.4. Latin America Gastrointestinal Cancer Devices Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Gastrointestinal Cancer Devices Market Analysis, 2018 – 2028 
          7.6.1.  MEA Gastrointestinal Cancer Devices Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Gastrointestinal Cancer Devices Market Size (US$), By Treatment Type, 2018 – 2028
          7.6.3. MEA Gastrointestinal Cancer Devices Market Size (US$), By End User, 2018 – 2028
          7.6.4. MEA Gastrointestinal Cancer Devices Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Gastrointestinal Cancer Devices Providers
        8.4.1 Eli Lilly and company
                8.4.1.1 Business Description
                8.4.1.2 Eli Lilly and company Geographic Operations
                8.4.1.3 Eli Lilly and company Financial Information
                8.4.1.4 Eli Lilly and company Product Positions/Portfolio
                8.4.1.5 Eli Lilly and company Key Developments
        8.4.2 F. Hoffmann-La Roche Ltd.
                8.4.2.1 Business Description
                8.4.2.2 F. Hoffmann-La Roche Ltd. Geographic Operations
                8.4.2.3 F. Hoffmann-La Roche Ltd. Financial Information
                8.4.2.4 F. Hoffmann-La Roche Ltd. Product Positions/Portfolio
                8.4.2.5 F. Hoffmann-La Roche Ltd. Key Developments
        8.4.3 GlaxoSmithKline plc
                8.4.3.1 Business Description
                8.4.3.2 GlaxoSmithKline plc Geographic Operations
                8.4.3.3 GlaxoSmithKline plc Financial Information
                8.4.3.4 GlaxoSmithKline plc Product Positions/Portfolio
                8.4.3.5 GlaxoSmithKline plc Key Developments
        8.4.4 Merck & Co., Inc.
                8.4.4.1 Business Description
                8.4.4.2 Merck & Co., Inc. Geographic Operations
                8.4.4.3 Merck & Co., Inc. Financial Information
                8.4.4.4 Merck & Co., Inc. Product Positions/Portfolio
                8.4.4.5 Merck & Co., Inc. Key Developments
        8.4.5 Novartis AG
                8.4.5.1 Business Description
                8.4.5.2 Novartis AG Geographic Operations
                8.4.5.3 Novartis AG Financial Information
                8.4.5.4 Novartis AG Product Positions/Portfolio
                8.4.5.5 Novartis AG Key Developments
        8.4.6 Otsuka Holdings Co., Ltd.
                8.4.6.1 Business Description
                8.4.6.2 Otsuka Holdings Co., Ltd. Geographic Operations
                8.4.6.3 Otsuka Holdings Co., Ltd. Financial Information
                8.4.6.4 Otsuka Holdings Co., Ltd. Product Positions/Portfolio
                8.4.6.5 Otsuka Holdings Co., Ltd. Key Developments
        8.4.7 Stryker Corporation
                8.4.7.1 Business Description
                8.4.7.2 Stryker Corporation Geographic Operations
                8.4.7.3 Stryker Corporation Financial Information
                8.4.7.4 Stryker Corporation Product Positions/Portfolio
                8.4.7.5 Stryker Corporation Key Developments
        8.4.8 Boston Scientific Corporation
                8.4.8.1 Business Description
                8.4.8.2 Boston Scientific Corporation Geographic Operations
                8.4.8.3 Boston Scientific Corporation Financial Information
                8.4.8.4 Boston Scientific Corporation Product Positions/Portfolio
                8.4.8.5 Boston Scientific Corporation Key Developments
        8.4.9 Johnson & Johnson
                8.4.9.1 Business Description
                8.4.9.2 Johnson & Johnson Geographic Operations
                8.4.9.3 Johnson & Johnson Financial Information
                8.4.9.4 Johnson & Johnson Product Positions/Portfolio
                8.4.9.5 Johnson & Johnson Key Developments
        8.4.10 CONMED Corporation
                8.4.10.1 Business Description
                8.4.10.2 CONMED Corporation Geographic Operations
                8.4.10.3 CONMED Corporation Financial Information
                8.4.10.4 CONMED Corporation Product Positions/Portfolio
                8.4.10.5 CONMED Corporation Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Gastrointestinal Cancer Devices Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Gastrointestinal Cancer Devices Market Revenue, By Treatment Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Gastrointestinal Cancer Devices Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Gastrointestinal Cancer Devices Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Gastrointestinal Cancer Devices Market Revenue, By Treatment Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Gastrointestinal Cancer Devices Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Gastrointestinal Cancer Devices Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Gastrointestinal Cancer Devices Market Revenue, By Treatment Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Gastrointestinal Cancer Devices Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Gastrointestinal Cancer Devices Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Gastrointestinal Cancer Devices Market Revenue, By Treatment Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Gastrointestinal Cancer Devices Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Gastrointestinal Cancer Devices Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Gastrointestinal Cancer Devices Market Revenue, By Treatment Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Gastrointestinal Cancer Devices Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Gastrointestinal Cancer Devices Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Gastrointestinal Cancer Devices: Market Segmentation 
FIG. 2 Global Gastrointestinal Cancer Devices Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Gastrointestinal Cancer Devices Market, By Treatment Type, 2019 (US$ Mn) 
FIG. 5 Global Gastrointestinal Cancer Devices Market, By End User, 2019 (US$ Mn) 
FIG. 6 Global Gastrointestinal Cancer Devices Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Gastrointestinal Cancer Devices Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Gastrointestinal Cancer Devices Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Gastrointestinal Cancer Devices Providers, 2019
FIG. 11 Global Gastrointestinal Cancer Devices Market Revenue Contribution, By Treatment Type, 2019 & 2028 (Value %) 
FIG. 12 Global Gastrointestinal Cancer Devices Market Revenue Contribution, By End User, 2019 & 2028 (Value %) 
FIG. 13 Global Gastrointestinal Cancer Devices Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Gastrointestinal Cancer Devices Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Gastrointestinal Cancer Devices Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Gastrointestinal Cancer Devices Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Gastrointestinal Cancer Devices Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Gastrointestinal Cancer Devices Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Gastrointestinal Cancer Devices market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Gastrointestinal Cancer Devices Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Gastrointestinal Cancer Devices Market Value, By Segment1, 2018 – 2028
TABLE  North America Gastrointestinal Cancer Devices Market Value, By Segment2, 2018 – 2028
TABLE  North America Gastrointestinal Cancer Devices Market Value, By Country, 2018 – 2028
TABLE  Europe Gastrointestinal Cancer Devices Market Value, By Segment1, 2018 – 2028
TABLE  Europe Gastrointestinal Cancer Devices Market Value, By Segment2, 2018 – 2028
TABLE  Europe Gastrointestinal Cancer Devices Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Gastrointestinal Cancer Devices Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Gastrointestinal Cancer Devices Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Gastrointestinal Cancer Devices Market Value, By Country, 2018 – 2028
TABLE  Latin America Gastrointestinal Cancer Devices Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Gastrointestinal Cancer Devices Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Gastrointestinal Cancer Devices Market Value, By Country, 2018 – 2028
TABLE  MEA Gastrointestinal Cancer Devices Market Value, By Segment1, 2018 – 2028
TABLE  MEA Gastrointestinal Cancer Devices Market Value, By Segment2, 2018 – 2028
TABLE  MEA Gastrointestinal Cancer Devices Market Value, By Country, 2018 – 2028
TABLE  Eli Lilly and company: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  F. Hoffmann-La Roche Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  GlaxoSmithKline plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Merck & Co., Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Novartis AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Otsuka Holdings Co., Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Stryker Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Boston Scientific Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Johnson & Johnson: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  CONMED Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Gastrointestinal Cancer Devices Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Gastrointestinal Cancer Devices Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Gastrointestinal Cancer Devices Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Gastrointestinal Cancer Devices Market, By Geography, 2019 (US$ Mn)
FIG.  Global Gastrointestinal Cancer Devices Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Gastrointestinal Cancer Devices Providers, 2016
FIG.  Global Gastrointestinal Cancer Devices Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Targeted Drugs Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Chemo Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Radiation Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Gastrointestinal Cancer Devices Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Ambulatory Surgery Centers Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Gastrointestinal Cancer Devices Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Gastrointestinal Cancer Devices Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Gastrointestinal Cancer Devices Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Gastrointestinal Cancer Devices Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Gastrointestinal Cancer Devices Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Gastrointestinal Cancer Devices Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Gastrointestinal Cancer Devices Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Gastrointestinal Cancer Devices Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Gastrointestinal Cancer Devices Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Gastrointestinal Cancer Devices Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Gastrointestinal Cancer Devices Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Gastrointestinal Cancer Devices Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Gastrointestinal Cancer Devices Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Gastrointestinal Cancer Devices Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Gastrointestinal Cancer Devices Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Gastrointestinal Cancer Devices Market Value, 2018 – 2028, (US$ Mn)